Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by earnings, at SAR 100.5B, ahead of Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B). Figures as of 18 Nov 2026, 19:45 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSAR 100.5B
- Median
- SAR 221.3M
- Combined market value
- SAR 18.96T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SAR 100.5B | SAR 2.47T | SAR 1,024.21 | 2.03% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SAR 77.4B | SAR 4.61T | SAR 5,178.05 | 2.48% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SAR 68.5B | SAR 1.27T | SAR 514.64 | 4.30% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | SAR 57B | SAR 651.2B | SAR 147.75 | 3.22% down | 17% down | ||
| 5 | NovartisNVS · Health Care | SAR 52.5B | SAR 1.1T | SAR 580.84 | 2.69% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SAR 38.4B | SAR 1.04T | SAR 669.20 | 2.12% down | 2% up | ||
| 7 | SanofiSNY · Health Care | SAR 32.5B | SAR 424.8B | SAR 176.92 | 0.77% down | 4% down | ||
| 8 | PfizerPFE · Health Care | SAR 29.1B | SAR 599.9B | SAR 105.25 | 1.44% down | 14% up | ||
| 9 | GSKGSK · Health Care | SAR 28.5B | SAR 365.4B | SAR 182.32 | 1.29% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SAR 26.5B | SAR 456.7B | SAR 223.45 | 2.90% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SAR 24.5B | SAR 679.4B | SAR 392.28 | 0.12% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | SAR 16.9B | SAR 366.9B | SAR 3,547.06 | 1.27% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | SAR 15.9B | SAR 1.89T | SAR 1,069.37 | 2.64% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | SAR 14.8B | SAR 510.8B | SAR 2,014.87 | 0.55% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | SAR 10B | SAR 130.6B | SAR 321.42 | 2.65% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 5.3B | SAR 184.4B | SAR 158.07 | 1.13% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | SAR 5B | SAR 92.4B | SAR 2,168.90 | 1.01% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | SAR 3.6B | SAR 118.5B | SAR 192.13 | 1.42% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SAR 2.9B | SAR 149.4B | SAR 259.76 | 0.83% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | SAR 2.6B | SAR 18.8B | SAR 225.32 | 0.48% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 1.7B | SAR 46.9B | SAR 56.21 | 1.32% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | SAR 1.7B | SAR 37.1B | SAR 245.65 | 4.43% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | SAR 1.7B | SAR 21.5B | SAR 31.60 | 2.38% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SAR 1.3B | SAR 44.4B | SAR 229.41 | 4.53% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | SAR 1.2B | SAR 74.6B | SAR 556.84 | 5.14% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | SAR 1.1B | SAR 173.1B | SAR 1,515.59 | 2.23% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | SAR 906.5M | SAR 29.2B | SAR 173.92 | 2.01% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | SAR 466.8M | SAR 22.4B | SAR 1,120.99 | 1.72% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | SAR 373.8M | SAR 27.8B | SAR 254.24 | 3.27% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SAR 270.3M | SAR 28.4B | SAR 81.64 | 3.05% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 221.3M | SAR 28B | SAR 356.14 | 0.17% down | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -SAR 6.1M | SAR 23B | SAR 162.61 | 0.84% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -SAR 87.6M | SAR 22.6B | SAR 346.67 | 0.51% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -SAR 95.8M | SAR 18.2B | SAR 189.54 | 1.12% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -SAR 262.6M | SAR 19.7B | SAR 467.82 | 0.73% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -SAR 291.1M | SAR 23.7B | SAR 582.66 | 1.51% down | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -SAR 395.5M | SAR 24.2B | SAR 357.51 | 1.05% down | 241% up | ||
| 38 | ErascaERAS · Health Care | -SAR 467.2M | SAR 17.7B | SAR 50.51 | 3.06% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -SAR 488.2M | SAR 30.7B | SAR 470.87 | 0.69% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -SAR 582.2M | SAR 35.6B | SAR 374.39 | 6.40% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -SAR 608.9M | SAR 18.1B | SAR 320.79 | 1.68% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -SAR 629.4M | SAR 17B | SAR 155.29 | 1.52% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -SAR 687.1M | SAR 26.4B | SAR 502.56 | 1.45% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -SAR 689.4M | SAR 14.7B | SAR 107.45 | 2.50% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -SAR 737.2M | SAR 31.1B | SAR 448.47 | 2.53% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -SAR 870.2M | SAR 50.3B | SAR 100.68 | 3.83% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -SAR 949M | SAR 66.4B | SAR 1,012.27 | 0.49% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -SAR 1.1B | SAR 35B | SAR 1,505.97 | 4.86% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -SAR 1.1B | SAR 11.8B | SAR 60.73 | 0.50% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -SAR 1.1B | SAR 104.7B | SAR 144.45 | 0.52% down | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -SAR 1.1B | SAR 32.1B | SAR 1,148.18 | 0.34% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -SAR 1.2B | SAR 18.3B | SAR 105.29 | 0.79% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -SAR 1.3B | SAR 59.2B | SAR 922.07 | 2.12% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -SAR 1.4B | SAR 27.4B | SAR 313.49 | 1.80% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -SAR 1.4B | SAR 17.3B | SAR 104.02 | 2.86% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -SAR 2.7B | SAR 56.8B | SAR 291.70 | 1.26% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -SAR 2.9B | SAR 26.8B | SAR 192.16 | 0.81% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -SAR 3.6B | SAR 254.9B | SAR 79.78 | 1.71% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -SAR 4B | SAR 31.7B | SAR 39.61 | 1.03% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -SAR 4.8B | SAR 99B | SAR 451.10 | 1.31% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -SAR 13.2B | SAR 88.5B | SAR 77.18 | 0.61% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceutical companies rank first by earnings?
Johnson & Johnson (SAR 100.5B), Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B) are the top three of the 61 pharmaceutical companies ranked by earnings as of 18 Nov 2026, 19:45 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of SAR 18.96T as of 18 Nov 2026, 19:45 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.